Center for Scientific Review; Notice of Closed Meetings, 53702-53703 [2010-21815]

Download as PDF 53702 Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices Period of Replacement Award: The period of support for the replacement award is June 1, 2010 to October 31, 2010. Authority: Section 330(h) of the Public Health Service Act, 42 U.S.C. 245b. CDFA Number: 93.703. Justification for Exception to Competition: The former grantee, Saint Vincent’s Catholic Medical Centers of New York, has relinquished all grants. Saint Vincent’s Catholic Medical Centers of New York’s inpatient services has closed, and Saint Vincent’s Catholic Medical Center of New York has filed for bankruptcy under Chapter 11. The former grantee has requested that HRSA transfer the Health Center Program Section 330(h) funds to SPHC in order to implement and carry out grant activities originally proposed under SVCMC funded Section 330(h) grant applications. SPHC has been engaged in the delivery of primary health care services in the local area and is a current Section 330 grantee who indicated an ability to assume operations without a disruption of services. The short-term transfer of the 330(h) funds will ensure that critical primary health care services continue and remain available to low-income, underserved, homeless patients with no interruption in services to the target population. FOR FURTHER INFORMATION CONTACT: BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2010–N–0389] Medical Device User Fee Act; Public Meeting; Request for Comments; Amendment of Notice hsrobinson on DSK69SOYB1PROD with NOTICES Food and Drug Administration, HHS. Notice. The Food and Drug Administration (FDA) is announcing an amendment to the notice of a public meeting on the reauthorization of the medical device user fee program. This meeting was announced in the Federal SUMMARY: 18:24 Aug 31, 2010 BILLING CODE 4160–01–S National Institute of Mental Health; Amended Notice of Meeting [FR Doc. 2010–21836 Filed 8–31–10; 8:45 am] VerDate Mar<15>2010 [FR Doc. 2010–21800 Filed 8–31–10; 8:45 am] National Institutes of Health Dated: August 26, 2010. Mary K. Wakefield, Administrator. ACTION: Dated: August 27, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. DEPARTMENT OF HEALTH AND HUMAN SERVICES Marquita Cullom-Scott via e-mail at MCullom-Scott@hrsa.gov or 301–594– 4300. AGENCY: Register of August 13, 2010 (75 FR 49502). The amendment is being made to include the exact meeting location, previously identified only as the Washington D.C. metropolitan area. There are no other changes. FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993, 301–796–6313, FAX: 301– 847–8121, email: James.Swink@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In the Federal Register of August 13, 2010 (75 FR 49502), FDA announced that a public meeting on the reauthorization of the medical device user fee program would be held on September 14, 2010. On page 49503, in the first column, the Location portion of the document is changed to read as follows: Location: The meeting will be held at the Marriott Inn and Conference Center, University of Maryland University College (UMUC), 3501 University Blvd. East, Hyattsville, MD 20783, www.marriott.com/wasum. Jkt 220001 Notice is hereby given of a change in the meeting of the Services Subcommittee of the Interagency Autism Coordinating Committee (IACC), September 13, 2010, 1 p.m. to 4 p.m., National Institute of Mental Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room A1/A2, Rockville, MD 20852, which was published in the Federal Register on August 19, 2010, 75 FR 51276. The meeting will not be Webcast as originally advertised. The meeting is open to the public and will still be accessible through a conference call phone number. The meeting will be held in the same place and same time. Dated: August 25, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21817 Filed 8–31–10; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Clinical Neuroscience and Neurodegeneration Study Section, September 30, 2010, 8 a.m. to October 1, 2010, 5 p.m., Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC, 20005 which was published in the Federal Register on August 4, 2010, 75 FR 46950–46951. The meeting will be one day only September 30, 2010. The meeting time and location remain the same. The meeting is closed to the public. Dated: August 26, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21816 Filed 8–31–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Developmental Biology. Date: September 14–15, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Noni Byrnes, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301) 435– 1023, byrnesn@csr.nih.gov. E:\FR\FM\01SEN1.SGM 01SEN1 hsrobinson on DSK69SOYB1PROD with NOTICES Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cancer Immunotherapy. Date: September 30, 2010. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Syed M Quadri, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301–435– 1211, quadris@csr.nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Cardiovascular and Sleep Epidemiology Study Section. Date: October 7–8, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: J. Scott Osborne, PhD, MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4114, MSC 7816, Bethesda, MD 20892, (301) 435– 1782, osbornes@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Molecular Genetics A Study Section. Date: October 7–8, 2010. Time: 8:30 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue, NW., Washington, DC 20037. Contact Person: Michael M Sveda, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 20892, 301–435– 3565, svedam@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Radiation Oncology. Date: October 7, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Syed M. Quadri, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301–435– 1211, quadris@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Urologic and Kidney Development and Genitourinary Diseases Study Section. Date: October 8, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. VerDate Mar<15>2010 18:24 Aug 31, 2010 Jkt 220001 Place: Crowne Plaza Washington National Airport, 1489 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Ryan G. Morris, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301–435– 1501, morrisr@csr.nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Musculoskeletal Rehabilitation Sciences Study Section. Date: October 8, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314. Contact Person: Jo Pelham, BA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4102, MSC 7814, Bethesda, MD 20892, (301) 435–1786, pelhamj@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Host Interactions with Bacterial Pathogens Study Section. Date: October 8, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact Person: Fouad A El-Zaatari, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD 20892, (301) 435– 1149, elzaataf@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 26, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21815 Filed 8–31–10; 8:45 am] 53703 Place: The teleconference will originate at the CDC. Status: Open to the public. Teleconference access limited only by the availability of telephone ports. The public is welcome to participate during the public comment period, which is tentatively scheduled from 2:45 p.m. to 2:50 p.m. To participate in the teleconference please dial (877) 394–7734 and enter conference code 9363147. Purpose: The Subcommittee will provide recommendations for consideration to the Advisory Committee to the Director on strategic and other broad issues facing CDC. Matters to be Discussed: Policy brief on health equity and social determinants of health; update on collaboration with the CDC Health Equity Workgroup; CDC Director’s Annual Health Disparity Report; and briefing on the realignment of the CDC Office of Minority Health and Health Disparities. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Walter W. Williams, M.D., M.P.H., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S E–67, Atlanta, Georgia 30333. Telephone (404) 498–2310, E-mail: www1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: August 24, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–21803 Filed 8–31–10; 8:45 am BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Health Disparities Subcommittee (HDS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces the following meeting of the aforementioned subcommittee: Time and Date: 2 p.m.–3 p.m., September 23, 2010. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\01SEN1.SGM 01SEN1

Agencies

[Federal Register Volume 75, Number 169 (Wednesday, September 1, 2010)]
[Notices]
[Pages 53702-53703]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21815]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Developmental Biology.
    Date: September 14-15, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Noni Byrnes, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301) 435-
1023, byrnesn@csr.nih.gov.

[[Page 53703]]

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Cancer Immunotherapy.
    Date: September 30, 2010.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Syed M Quadri, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301-435-
1211, quadris@csr.nih.gov.

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Cardiovascular and Sleep Epidemiology Study 
Section.
    Date: October 7-8, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: J. Scott Osborne, PhD, MPH, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4114, MSC 7816, Bethesda, MD 
20892, (301) 435-1782, osbornes@csr.nih.gov.

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Molecular Genetics A Study Section.
    Date: October 7-8, 2010.
    Time: 8:30 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue, 
NW., Washington, DC 20037.
    Contact Person: Michael M Sveda, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 20892, 301-435-
3565, svedam@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Radiation Oncology.
    Date: October 7, 2010.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Syed M. Quadri, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301-435-
1211, quadris@csr.nih.gov.

    Name of Committee: Digestive, Kidney and Urological Systems 
Integrated Review Group; Urologic and Kidney Development and 
Genitourinary Diseases Study Section.
    Date: October 8, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza Washington National Airport, 1489 Jefferson 
Davis Highway, Arlington, VA 22202.
    Contact Person: Ryan G. Morris, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301-435-
1501, morrisr@csr.nih.gov.

    Name of Committee: Musculoskeletal, Oral and Skin Sciences 
Integrated Review Group; Musculoskeletal Rehabilitation Sciences 
Study Section.
    Date: October 8, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, 
VA 22314.
    Contact Person: Jo Pelham, BA, Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 4102, MSC 7814, Bethesda, MD 20892, (301) 435-1786, 
pelhamj@csr.nih.gov.

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Host Interactions with Bacterial Pathogens 
Study Section.
    Date: October 8, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
    Contact Person: Fouad A El-Zaatari, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD 
20892, (301) 435-1149, elzaataf@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 26, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-21815 Filed 8-31-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.